Medetomidine Related Compounds & Impurities

Medetomidine is a potent alpha-2 adrenergic agonist sedative and analgesic used in veterinary medicine for procedural sedation.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Medetomidine reference standards, pharmacopeial and non-pharmacopeial Medetomidine impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Medetomidine-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Medetomidine
Medetomidine Hydrochloride
Medetomidine Hydroxy Impurity
Dexmedetomidine Hydrochloride
Dexmedetomidine
N-Benzyl hydroxymedetomidine
Ethylmedetomidine
Ethylmedetomidine
N-Benzyl medetomidine Hydrochloride
Medetomidine N-Benzyl Vinyl Analog
Dexmedetomidine Related Compound B
1-Bromo-2,3-dimethylbenzene
Methyl 1H-Imidazole-5-carboxylate
Dexmedetomidine Related Compound B
1-Hydroxy N-Trityl Medetomidine
Dexmedetomidine Impurity II
Dexmedetomidine Impurity III
Dexmedetomidine Ketone Impurity
Dexmedetomidine Oletine Impurity
(S)-4-[1-(2,3-dimethylphenyl)ethyl-1H-imidazole
4-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole L-Tartaric acid
4-(1-(2,4-dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric acid
4-(1-(2,5-dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric acid
4-(1-(2,6-dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric acid
4-(1-(3,4-dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric acid
Triphenylmethane
Dexmedetomidine Impurity IV
5-Imidazolecarboxaldehyde
Medetomidine Impurity 2
4-(Hydroxymethyl)imidazole Hydrochloride
Dexmedetomidine Impurity III ( (2,3-Dimethylphenyl)[1-(trityl)-1H-imidazol-4-yl]methanone)
Medetomidine
Medetomidine Impurity 5
Medetomidine Chloro Impurity
Dexmedetomidine hydrochloride
3-Hydroxy Medetomidine
N3-Benzyl vinyl analog medetomidine
Dexmedetomidine Nitroso Impurity
Medetomidine impurity 1
Medetomidine Impurity 3
Medetomidine Impurity 4
Medetomidine Impurity 6
Medetomidine Impurity 7
Medetomidine Impurity 8
Medetomidine Impurity 9
Medetomidine Impurity 10
Medetomidine Impurity 11

Isotope Labelled Compounds

Dexmedetomidine D3 Tartrate
Dexmedetomidine-13C-D3 Hydrochloride